Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

LESSONS LEARNED: Trials focusing on unresectable multifocal glioblastoma are needed because of the extremely poor prognosis and challenges in receiving standard therapy, such as concurrent radiation and chemotherapy. Developing a strategy to chemically debulk tumors before radiation and/or surgery i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Peters, Katherine B., Lou, Emil, Desjardins, Annick, Reardon, David A., Lipp, Eric S., Miller, Elizabeth, Herndon, James E., McSherry, Frances, Friedman, Henry S., Vredenburgh, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492239/
https://ncbi.nlm.nih.gov/pubmed/26025933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0135
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados